Physician profile
Salvatore J Pacella
NPI 1316069503
$517,438.91
in general payments reported to CMS, 2019-2025
23 companies · $89K in 2025
The $89K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $30K · 2021: $23K · 2022: $47K · 2023: $159K · 2024: $126K · 2025: $89K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $244K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $61K · Travel and Lodging: $45K · Food and Beverage: $8,004 · Education: $6,000 · Honoraria: $4,620 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,710 · Grant: $1,453 · Other payment types: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $243,668.20 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $61,180.00 |
| Travel and Lodging | $45,217.15 |
| Food and Beverage | $8,004.17 |
| Education | $6,000.00 |
| Honoraria | $4,620.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,710.00 |
| Grant | $1,453.20 |
| Other payment types | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $267,402.42 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kerecis Limited | $142,307.40 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Mentor Worldwide LLC | $50,254.59 | 2019-2025 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Medical Device Business Services, INC. | $30,260.95 | 2019-2022 | |
| Motiva USA, LLC | $18,477.63 | 2024-2025 | |
| Rti Surgical, INC | $2,455.36 | 2025 | |
| Sientra, INC. | $2,038.77 | 2020-2022 | |
| Bimini Technologies LLC | $1,500.00 | 2025 | |
| Biom'Up France Sas | $1,000.00 | 2021 | |
| Innovation Technologies INC | $379.77 | 2023-2024 | Irrisept |
| Bard Peripheral Vascular, INC. | $367.75 | 2021 | |
| Abbvie INC. | $200.75 | 2023-2024 | |
| Kls-Martin L.P. | $158.87 | 2024 | |
| Polynovo North America LLC | $152.78 | 2023 | |
| Axogen | $150.00 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $97.23 | 2025 | Phasix Mesh |
| Allergan, INC. | $64.20 | 2021-2022 | |
| Acera Surgical, INC. | $49.45 | 2023-2024 | Restrata Wound Matrix |
| Histosonics, INC. | $35.07 | 2024 | |
| Access Pro Medical, LLC | $33.96 | 2022 | |
| Galderma Laboratories, L.P. | $27.14 | 2020 | |
| Ethicon US, LLC | $13.49 | 2023 | Surgicel Nu-Knit |
| Apyx Medical Corporation | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salvatore Pacella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.